Endocrine Abstracts (2006) 11 P857

A novel test with recombinant human TSH for the differential diagnosis of congenital hypothryoidism in pediatric age

L Fugazzola1, G Weber3, D Mannavola1, G Vannucchi1, M Carletto4, V Longari4, L Persani2 & P Beck-Peccoz1


1Institute of Endocrine Sciences, Fondazione Policlinico IRCCS, Milan, Italy; 2Institute of Endocrine Sciences, Istituto Auxologico Italiano IRCCS, Milan, Italy; 3Pediatric Department, Università Vita-Salute San Raffaele, Milan, Italy; 4Department of Nuclear Medicine, Fondazione Policlinico IRCCS, Milan, Italy.


Congenital hypothyroidism (CH) affects 1:2.000–3.000 newborns. In most cases, the cause is a developmental defect (dysgenesia) or an arrested migration (ectopia) of the thyroid gland. In the remaining cases TSH resistance or defects in iodide transport or thyroid hormonogenesis account for CH. The differential diagnosis is aimed to recognize permanent CH forms and to achieve an etiologic diagnosis for accurate management and genetic counselling. Appropriate investigations are in most cases performed at 3–4 years of age, after 1 month L-thyroxine withdrawal. In this study, a novel rhTSH (Thyrogen®) protocol has been tested after approval by Institutional Ethical Committee and informed consent in 8 patients, aged 17 months-12 years, during L-T4 treatment. In the presence of a normally positioned thyroid gland at ultrasound, 2 i.m. injections (0.004 mg/kg) were administered at days 1 and 2, and thyroid uptake with 123I+ perchlorate test (200–500 mg of KClO4) were performed at day 3. In the case of apparent agenesia, 3 rhTSH injections were administered at days 1–3, with neck scintigraphy uptake at days 3 and 4. In all cases, blood was sampled at baseline and at day 3 for TSH and thyroglobulin (Tg) levels. Side effects were not observed in any patients. Basal TSH levels were normal at baseline and peaked at day 3 (range: 15–47 mU/l). Tg levels increased after stimulation in 7/8 patients. At scintigraphy, in a patient previously classified as affected with agenesia, a sublingual thyroid (ectopia) was revealed. Two patients had a large thyroid with a positive perchlorate test (discharge=100%, indicating a total organification defect), while 5 patients had a normally positioned gland with normal uptake and negative perchlorate test (indicating transient CH or partial TSH resistance). In conclusion, we report a novel rhTSH protocol for the differential diagnosis of CH performed during L-T4 treatment in childhood. This test not only led to the correct diagnosis in all cases but also allowed the specific patient management and the targeted genetic analyses. rhTSH test represents a valid alternative to L-T4 withdrawal, avoiding untoward effects of transient hypothyroidism in CH infants.

Article tools

My recent searches

No recent searches.